antipsychotics
Clinical teaching and practical ideas for your next study session.
Olanzapine and Insulin Resistance: How Specific Should a Board Answer Be?
A direct-mechanism MCQ can tempt you to state more than the evidence supports. Learn the classic insulin-signaling answer, distinguish a cell-model finding from a small human physiology study, and avoid treating a proposed GLUT4 effect as a universal explanation.
Antipsychotic Metabolic Risk on Psychiatry Boards: Read the Endpoint Before You Choose
A broad question about antipsychotic metabolic risk can hide an important ambiguity: the answer changes with the endpoint and duration. Learn how to reason through the pharmacology, identify common traps, and turn one MCQ into durable retrieval practice.
Antipsychotic Weight Gain: Why Olanzapine and Clozapine Are Among the Highest-Risk Drugs
When weight gain is a major treatment concern, olanzapine is the classic board-style answer—but clozapine belongs in the same high-risk tier. Learn how comparative evidence, duration of follow-up, patient history, and monitoring should shape the choice without oversimplifying it.